Differentially expressed genes in window trials are influenced by the wound-healing process: Lessons learned from a pilot study with anastrozole

Journal of Surgical Research

Volumn 176, Issue 1, 2012, Pages 121-132

  Morrogh, Mary ^a   Andrade, Victor P ^a   Patil, Asawari J ^a   Qin, Li Xuan ^a   Mo, Qianxing ^a   Sakr, Rita ^a   Arroyo, Crispinita D ^a   Brogi, Edi ^a   Morrow, Monica ^a   King, Tari A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

aromatase inhibition; breast cancer; gene expression; preoperative window trials; proliferation

Indexed keywords

ANASTROZOLE; BAG1 PROTEIN; CATECHOL METHYLTRANSFERASE; CD34 ANTIGEN; COLLAGEN TYPE 18; COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; CULLIN; CULLIN 2; CYCLIN DEPENDENT KINASE 4; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 4; ESTROGEN RECEPTOR; GAMMA INTERFERON RECEPTOR 1; ING1 PROTEIN; INTEGRIN LINKED KINASE; KI 67 ANTIGEN; MEL PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; PRG PROTEIN; PROTEIN; PROTEIN FOS; PROTEIN KINASE LYN; RAD23A PROTEIN; RAD51 PROTEIN; RAP1GDS1 PROTEIN; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F5; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER HORMONE THERAPY; CANCER SURGERY; CANCER TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA REPAIR; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; FROZEN SECTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIMODALITY CANCER THERAPY; PILOT STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR BIOPSY; WOUND HEALING;

AGED; AGED, 80 AND OVER; ANTIGENS, CD34; AROMATASE INHIBITORS; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NITRILES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING; PILOT PROJECTS; PREOPERATIVE PERIOD; TRIAZOLES; TUMOR MARKERS, BIOLOGICAL; WOUND HEALING;

EID: 84862019650     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.05.058     Document Type: Article

References (31)

1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials Lancet 365 2005 1687
2. J.C. Chang, A. Makris, and M.C. Gutierrez Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients Breast Cancer Res Treat 108 2008 233
3. S. Paik, S. Shak, and G. Tang A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2004 2817
4. Dixon M. A study looking at the changes in the breast cancer of postmenopausal women having hormone therapy. Primary Endocrine Response Study, Edinburgh, UK. http://www.cancerhelp.org.uk/trials/. Accessed June 27, 2011.
5. Smith I. A trial of a short course of hormone therapy before and after surgery for early breast cancer (POETIC). Edinburgh, UK. http://www.cancerhelp. org.uk/trials/. Accessed June 27, 2011.
6. S. Kagawa, A. Matsuo, and Y. Yagi The time-course analysis of gene expression during wound healing in mouse skin Leg Med (Tokyo) 11 2009 70
7. G.K. Smyth Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 3 2004 (Article No. 3)
8. M. Mello-Grand, V. Singh, and C. Ghimenti Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer Breast Cancer Res Treat 121 2010 399
9. A. Mackay, A. Urruticoechea, and J.M. Dixon Molecular response to aromatase inhibitor treatment in primary breast cancer Breast Cancer Res 9 2007 R37
10. L. Cooper, C. Johnson, and F. Burslem Wound healing and inflammation genes revealed by array analysis of 'macrophageless' PU.1 null mice Genome Biol 6 2005 R5
11. D.H. Gorski, and K. Walsh Control of vascular cell differentiation by homeobox transcription factors Trends Cardiovasc Med 13 2003 213
12. X. Shi-Wen, A. Leask, and D. Abraham Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis Cytokine Growth Factor Rev 19 2008 133
13. Y. Li, J. Yang, and C. Dai Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis J Clin Invest 112 2003 503
14. Q. Yan, W. Sui, and S. Xie Expression and role of integrin-linked kinase and collagen IV in human renal allografts with interstitial fibrosis and tubular atrophy Transpl Immunol 23 2010 1
15. S. Peroukides, V. Bravou, and J. Varakis ILK overexpression in human hepatocellular carcinoma and liver cirrhosis correlates with activation of Akt Oncol Rep 20 2008 1337
16. C. Sobolewski, C. Cerella, and M. Dicato The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies Int J Cell Biol 2010 2010 1
17. A. Nassar, A. Radhakrishnan, and I.A. Cabrero COX-2 expression in invasive breast cancer: Correlation with prognostic parameters and outcome Appl Immunohistochem Mol Morphol 15 2007 255
18. A. Ristimaki, A. Sivula, and J. Lundin Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res 62 2002 632
19. K.J. Schmitz, R. Callies, and J. Wohlschlaeger Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways J Clin Pathol 59 2006 685
20. W.R. Miller, A.A. Larionov, and L. Renshaw Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole Pharmacogenet Genomics 17 2007 813
21. K.S. Midwood, L.V. Williams, and J.E. Schwarzbauer Tissue repair and the dynamics of the extracellular matrix Int J Biochem Cell Biol 36 2004 1031
22. M. Retsky, R. Demicheli, and W. Hrushesky Wounding from biopsy and breast-cancer progression Lancet 357 2001 1048
23. M. Retsky, R. Demicheli, and W.J. Hrushesky Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox Int J Surg 3 2005 179
24. W.R. Miller, S. White, and J.M. Dixon Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole Br J Cancer 94 2006 1051
25. A. Cvoro, D. Tatomer, and M.K. Tee Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes J Immunol 180 2008 630
26. R.B. Clarke, I.J. Laidlaw, and L.J. Jones Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status Br J Cancer 67 1993 606
27. M. Dowsett, I.E. Smith, and S.R. Ebbs Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival Clin Cancer Res 11 2005 951s
28. M.J. Ellis, A. Coop, and B. Singh Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status Cancer Res 63 2003 6523
29. M. Dowsett, S.R. Ebbs, and J.M. Dixon Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: Influence of hormonal status and HER-2 in breast cancer-A study from the IMPACT trialists J Clin Oncol 23 2005 2477
30. M. Dowsett, I.E. Smith, and S.R. Ebbs Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer J Natl Cancer Inst 99 2007 167
31. M.J. Ellis, Y. Tao, and J. Luo Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics J Natl Cancer Inst 100 2008 1380